Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy

Dimensions

Chitra, Pachiappan and Bakthavatsalam, Balakrishnan and Palvannan, Thayumanavan (2011) Beta-2 microglobulin as an immunological marker to assess the progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy. Clinica Chimica Acta, 412 (11-12). pp. 1151-1154. ISSN 00098981

Full text not available from this repository.

Abstract

Serum β-2 microglobulin (B2M) was evaluated as a marker of HIV progression in 50 patients on HAART. Increased B2M correlated with decreased CD4/CD8 counts and WBCs, and positively correlated with viral RNA and LDH. B2M may indicate immune progression in HIV with interrupted HAART. © 2011 Elsevier B.V., All rights reserved.

Item Type: Article
Subjects: Medicine > Immunology and Allergy
Divisions: Medicine > Vinayaka Mission's Kirupananda Variyar Medical College and Hospital, Salem > Biochemistry
Depositing User: Unnamed user with email techsupport@mosys.org
Last Modified: 10 Dec 2025 07:01
URI: https://vmuir.mosys.org/id/eprint/4318

Actions (login required)

View Item
View Item